INS and diabetes mellitus: Remarkably, subcutaneously injection of FGF1 protein can significantly improve the insulin sensitivity and reduce the serum glucose levels in two mouse models of diabetes (ob/ob, db/db and diet-induced obese insulin resistant mice).